Zyprexa Relprevv

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Olanzapine pamoate monohydrate

Pieejams no:

Eli Lilly Australia Pty Ltd

Klase:

Medicine Registered

Lietošanas instrukcija

ZYPREXA RELPREVV
®

_Olanzapine pamoate monohydrate_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet is designed to provide
you with answers to some common
questions about this medicine. It does
not contain all the available
information and does not take the
place of talking with your doctor.
The information in this leaflet was
last updated on the date shown on the
final page. More recent information
on this medicine may be available.
Make sure you speak to your
pharmacist, nurse or doctor to obtain
the most up to date information on
this medicine. You can also
download the most up to date leaflet
from www.lilly.com.au. The updated
leaflet may contain important
information about ZYPREXA
RELPREVV and its use that you
should be aware of.
All medicines have risks and
benefits.
Your doctor has more information
about this medicine than is contained
in this leaflet. Also, your doctor has
had the benefit of taking a full and
detailed history from you and is in
the best position to make an expert
judgement to meet your individual
needs.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THIS
MEDICINE.
You may need to read it again.
WHAT ZYPREXA
RELPREVV IS USED FOR
ZYPREXA RELPREVV belongs to a
group of medicines called
antipsychotics. It helps to correct
chemical imbalances in the brain,
which may cause mental illness.
ZYPREXA RELPREVV is used to
treat symptoms of schizophrenia.
Schizophrenia is a mental illness
with disturbances in thinking,
feelings and behaviour.
ZYPREXA RELPREVV is given as
an injection into a large muscle in the
buttocks where it is slowly released
over 2 to 4 weeks. This injection
should only be given by a doctor or
nurse.
Your doctor may have prescribed
ZYPREXA RELPREVV for another
reason.
ASK YOUR DOCTOR OR NURSE IF YOU
HAVE ANY QUESTIONS ABOUT WHY
ZYPREXA RELPREVV HAS BEEN
PRESCRIBED FOR YOU.
This medicine is available only with
a doctor's prescription.
ZYPREXA RELPREVV is not
recommended for use in c

Produkta apraksts

 
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate)
Product Information v9.0Page 4 of 23

ZYPREXA

RELPREVV
®

(olanzapine pamoate monohydrate) 

WARNING: The potential for signs and symptoms of sedation and/or
delirium 
consistent with olanzapine overdose exists after
every injection of ZYPREXA 
RELPREVV.  ZYPREXA RELPREVV should be administered by appropriately 
qualified health professionals
in a healthcare facility with access to emergency 
services for management of olanzapine overdose.  Healthcare
professionals who 
prescribe or administer ZYPREXA RELPREVV should be aware of this
potential 
risk and the consequent need to monitor
patients for at least two hours after each 
injection. The two hour period should be extended as
clinically appropriate for 
patients who exhibit any potential signs or
symptoms of a post-injection syndrome 
event. See PRECAUTIONS, Post-Injection Syndrome. 

NAME OF THE MEDICINE 
ZYPREXA RELPREVV (olanzapine pamoate monohydrate 
– alternatively named 
olanzapine embonate monohydrate). 
Chemically, olanzapine pamoate monohydrate is 10_H_-thieno[2,3-
_b_][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-,4,4'-methylenebis[3-
hydroxy-2-naphthalene-carboxylate] (1:1), monohydrate. The formula is 
C
17
H
22
N
4
SC
23
H
14
O
6
H
2
O. Olanzapine pamoate monohydrate is a yellow solid that 
is practically insoluble in water with a molecular
weight of 718.8. The CAS number 
for olanzapine pamoate monohydrate is 221373-18-8. 
Olanzapine pamoate monohydrate has the following structural
formula: 

DESCRIPTION 
ZYPREXA RELPREVV is
supplied in a kit containing two vials, one containing 
powder
and one containing a sterile diluent, one syringe with fixed needle and two 
needles. ZYPREXA RELPREVV is a yellow powder for
suspension in a clear glass 
vial.  The active ingredient in ZYPREXA